title: Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.
authors.affiliation: Department of Obstetrics and Gynecology Wayne, State Universits/Detroit Medical Center, Michigan, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Tomlinson
authors.forename: M C
authors.initials: MC
authors.lastname: Treadwell
authors.forename: G
authors.initials: G
authors.lastname: Deppe
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D018310:Sertoli-Leydig Cell Tumor / Q000188:drug therapy*
chemical_list: D005047:Etoposide; D002945:Cisplatin